|
US2086186A
(en)
|
1933-10-10 |
1937-07-06 |
Us Rubber Co |
Treatment of rubber
|
|
GB1435721A
(en)
|
1972-05-18 |
1976-05-12 |
Lilly Industries Ltd |
Benzoxazole derivatives
|
|
SU509046A1
(ru)
|
1975-02-21 |
1984-06-23 |
Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе |
Производные 2-карбэтокси-3-аминоиндола,про вл ющие противовоспалительную активность, и способ их получени
|
|
US4675332A
(en)
|
1984-12-10 |
1987-06-23 |
Warner-Lambert Company |
Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
|
|
GB8610981D0
(en)
|
1986-05-06 |
1986-06-11 |
Ici America Inc |
Quinoline amides
|
|
NZ225045A
(en)
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
EP0506949A1
(en)
|
1990-10-22 |
1992-10-07 |
BAUSCH & LOMB INCORPORATED |
Method and composition for cleaning contact lenses
|
|
AU641052B2
(en)
|
1990-11-02 |
1993-09-09 |
Aventisub Ii Inc. |
3-amidoindolyl derivatives
|
|
US5668117A
(en)
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
|
US6444221B1
(en)
|
1992-06-30 |
2002-09-03 |
Howard K. Shapiro |
Methods of treating chronic inflammatory diseases using carbonyl trapping agents
|
|
US5472954A
(en)
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
|
TW401300B
(en)
|
1992-12-25 |
2000-08-11 |
Senju Pharma Co |
Antiallergic composition for ophthalmic or nasal use
|
|
US5493027A
(en)
|
1993-01-22 |
1996-02-20 |
Board Of Regents, The University Of Texas System |
Anticonvulsive agents and uses thereof
|
|
US5767109A
(en)
|
1993-10-20 |
1998-06-16 |
Sanchez; Robert A. |
Complexing urushiols
|
|
US5576311A
(en)
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
|
JP3297969B2
(ja)
|
1994-12-26 |
2002-07-02 |
ライオン株式会社 |
点眼剤
|
|
US5597823A
(en)
|
1995-01-27 |
1997-01-28 |
Abbott Laboratories |
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
|
|
JP3736916B2
(ja)
|
1996-02-19 |
2006-01-18 |
株式会社サンコンタクトレンズ |
含水性ソフトコンタクトレンズの消毒用組成物とその用途
|
|
BR9711110A
(pt)
|
1996-08-01 |
1999-08-17 |
Dow Agrosciences Lic |
Derivados de quinolina 4-substituidos tendo a atividade fungicida
|
|
WO1998050372A1
(de)
|
1997-05-02 |
1998-11-12 |
Schering Aktiengesellschaft |
Substituierte heterocyclen und deren verwendung in arzneimitteln
|
|
GB2327672A
(en)
|
1997-07-23 |
1999-02-03 |
Merck & Co Inc |
4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7-yl)butanoyl-glycyl-3(S)-quinolin-3-yl-beta-alanine
|
|
EP1080068A1
(en)
|
1998-03-12 |
2001-03-07 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases
|
|
US6498154B1
(en)
|
1999-05-04 |
2002-12-24 |
Wyeth |
Cyclic regimens using quinazolinone and benzoxazine derivatives
|
|
US6358948B1
(en)
|
1999-05-04 |
2002-03-19 |
American Home Products Corporation |
Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
|
|
JP2003514019A
(ja)
|
1999-11-15 |
2003-04-15 |
スミスクライン・ビーチャム・コーポレイション |
カルベジロールメタンスルホン酸塩
|
|
AU1735001A
(en)
|
1999-12-10 |
2001-06-18 |
Senju Pharmaceutical Co., Ltd. |
Cyclodextrin-containing pharmaceutical composition
|
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
JP4748289B2
(ja)
|
2000-06-23 |
2011-08-17 |
ライオン株式会社 |
点眼剤、眼科用組成物及び吸着抑制方法
|
|
FR2827599A1
(fr)
|
2001-07-20 |
2003-01-24 |
Neuro3D |
Composes derives de quinoleine et quinoxaline,preparation et utilisations
|
|
UA83620C2
(ru)
|
2001-12-05 |
2008-08-11 |
Уайт |
Замещенные бензоксазолы и их аналоги как эстрогенные агенты
|
|
US20060014786A1
(en)
|
2002-05-17 |
2006-01-19 |
Rajeev Raut |
Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
US20040198828A1
(en)
|
2003-01-17 |
2004-10-07 |
Abelson Mark B. |
Combinational use of long-acting and short-acting anti-histamines for ocular allergies
|
|
EP2327401A3
(en)
|
2003-03-14 |
2011-10-19 |
University of Washington |
Retinoid Replacements and Opsin Agonists and Methods for the Use Thereof
|
|
EP2292239A3
(en)
|
2003-04-18 |
2011-03-30 |
Advanced Medicine Research Institute |
Remedies for diseases to be applied to eye
|
|
US20060111318A1
(en)
|
2003-04-18 |
2006-05-25 |
Advanced Medicine Research Institute |
Agent for treating eye diseases
|
|
US7297709B2
(en)
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
|
US20040235892A1
(en)
|
2003-05-22 |
2004-11-25 |
Yujia Dai |
Indazole and benzisoxazole kinase inhibitors
|
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
ES2426288T3
(es)
|
2003-10-15 |
2013-10-22 |
Ube Industries, Ltd. |
Novedoso derivado de imidazol
|
|
BRPI0415863A
(pt)
|
2003-10-27 |
2007-01-09 |
Astellas Pharma Inc |
derivados pirazina e seus usos farmacêuticos
|
|
AU2004293105B2
(en)
|
2003-11-20 |
2010-09-09 |
Othera Holding, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
US20050197292A1
(en)
|
2004-01-30 |
2005-09-08 |
Glennda Smithson |
Compositions and methods for treating T-cell mediated pathological conditions
|
|
EP1722766A2
(en)
|
2004-02-17 |
2006-11-22 |
President And Fellows Of Harvard College |
Management of ophthalmologic disorders, including macular degeneration
|
|
US20050234018A1
(en)
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
|
WO2006002473A1
(en)
|
2004-07-02 |
2006-01-12 |
Adelaide Research & Innovation Pty Ltd |
Method of controlling damage mediated by alpha, beta-unsaturated aldehydes
|
|
CA2585210A1
(en)
|
2004-10-28 |
2006-05-11 |
Merck & Co., Inc. |
Pyrimidine and quinoline potentiators of metabotropic glutamate receptors
|
|
US20100160304A1
(en)
|
2005-01-19 |
2010-06-24 |
Dainippon Sumitomo Pharma Co., Ltd |
Aromatic sulfone compound as aldosterone receptor modulator
|
|
TW200640443A
(en)
|
2005-02-23 |
2006-12-01 |
Alcon Inc |
Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
|
|
CA2609659C
(en)
|
2005-05-26 |
2014-01-28 |
Neuron Systems, Inc. |
Azanaphthalenes, compositions and methods for treating retinal disease
|
|
JP4466875B2
(ja)
|
2006-04-05 |
2010-05-26 |
ライオン株式会社 |
ソフトコンタクトレンズ用点眼剤
|
|
CN101987849B
(zh)
|
2006-04-14 |
2013-05-08 |
普拉纳生物技术有限公司 |
治疗与年龄相关的黄斑变性(amd)的方法
|
|
JP5194218B2
(ja)
|
2006-06-05 |
2013-05-08 |
株式会社メニコンネクト |
含水性コンタクトレンズの保存方法ならびに該保存方法により保存された含水性コンタクトレンズ
|
|
RU2009106461A
(ru)
|
2006-07-25 |
2010-08-27 |
Энвиво Фармасьютикалз, Инк. (Us) |
Хинолиновые производные
|
|
US8158609B1
(en)
|
2006-11-02 |
2012-04-17 |
Novartis Ag |
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
|
|
TW200914437A
(en)
|
2007-06-20 |
2009-04-01 |
Ironwood Pharmaceuticals Inc |
FAAH inhibitors
|
|
MY160052A
(en)
|
2007-10-05 |
2017-02-15 |
Acucela Inc |
Alkoxy compounds for disease treatment
|
|
CN101969938A
(zh)
|
2008-02-11 |
2011-02-09 |
华盛顿大学 |
治疗和预防年龄相关视网膜功能障碍的方法
|
|
KR20110044291A
(ko)
|
2008-08-12 |
2011-04-28 |
서트리스 파마슈티컬즈, 인코포레이티드 |
시르투인 조절제로서의 벤족사졸, 벤즈티아졸 및 관련 유사체
|
|
JP2012520880A
(ja)
|
2009-03-17 |
2012-09-10 |
アーシエックス セラピューティックス， インコーポレイテッド |
ケトチフェンの眼科用製剤および使用方法
|
|
WO2010133672A1
(en)
|
2009-05-20 |
2010-11-25 |
Clanotech Ab |
Derivatives of quinoline-3-carboxylic acid and their medical use
|
|
WO2010148351A1
(en)
|
2009-06-18 |
2010-12-23 |
Cylene Pharmaceuticals, Inc. |
Rhodanines and related heterocycles as kinase inhibitors
|
|
WO2011008202A1
(en)
|
2009-07-15 |
2011-01-20 |
Vanderbilt University |
Isoketal scavengers and mitigation of disorders involving oxidative injury
|
|
JP5815552B2
(ja)
|
2009-12-08 |
2015-11-17 |
ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ |
眼疾患を治療する化合物および方法
|
|
JP5885670B2
(ja)
|
2009-12-11 |
2016-03-15 |
アルデイラ セラピューティクス， インコーポレイテッド |
黄斑変性の処置のための組成物および方法
|
|
WO2011078204A1
(ja)
|
2009-12-24 |
2011-06-30 |
浜理薬品工業株式会社 |
高脂血症の予防または治療剤、および抗疲労剤
|
|
WO2011116066A1
(en)
|
2010-03-17 |
2011-09-22 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
|
PL2663550T3
(pl)
|
2011-01-12 |
2017-07-31 |
Ventirx Pharmaceuticals, Inc. |
Podstawione benzoazepiny jako modulatory receptora toll-podobnego
|
|
WO2012100142A2
(en)
|
2011-01-20 |
2012-07-26 |
Cornell University |
Treatments for retinal disorders
|
|
WO2012105887A1
(en)
|
2011-01-31 |
2012-08-09 |
Tim Bowden |
Active principle for mitigating undesired medical conditions
|
|
TWI544922B
(zh)
|
2011-05-19 |
2016-08-11 |
愛爾康研究有限公司 |
高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
|
|
US20130190500A1
(en)
*
|
2011-12-12 |
2013-07-25 |
Neuron Systems, Inc. |
Process to prepare 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanaphthalene
|
|
US20130165419A1
(en)
|
2011-12-21 |
2013-06-27 |
Insite Vision Incorporated |
Combination anti-inflammatory ophthalmic compositions
|
|
CA2880040A1
(en)
|
2012-08-01 |
2014-02-06 |
Lewis And Clark Pharmaceuticals, Inc. |
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as a2a agonists
|
|
SG11201503637SA
(en)
|
2012-11-08 |
2015-06-29 |
Clearside Biomedical Inc |
Methods and devices for the treatment of ocular diseases in human subjects
|
|
CA2896032A1
(en)
|
2012-12-20 |
2014-06-26 |
Aldeyra Therapeutics, Inc. |
Peri-carbinols
|
|
CN111135171B
(zh)
*
|
2013-01-23 |
2023-09-08 |
奥尔德拉医疗公司 |
与毒性醛相关的疾病和治疗
|
|
JP6266023B2
(ja)
*
|
2013-01-25 |
2018-01-24 |
アルデイラ セラピューティクス， インコーポレイテッド |
黄斑変性症の処置における新規トラップ
|
|
US9713330B1
(en)
|
2013-03-15 |
2017-07-25 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
|
US10272106B2
(en)
|
2014-06-04 |
2019-04-30 |
Case Western Reserve University |
Compositions and methods of treating diabetic retinopathy
|
|
NO2721710T3
(enExample)
|
2014-08-21 |
2018-03-31 |
|
|
|
EP3628640B1
(en)
|
2014-09-02 |
2023-08-09 |
Hub Therapeutics |
Methods of making a deuterated or a non-deuterated molecule and pharmaceutical formulations for treatment
|
|
WO2016085939A2
(en)
|
2014-11-24 |
2016-06-02 |
Case Western Reserve University |
Compounds and methods of treating ocular disorders
|
|
EP3337470A4
(en)
|
2015-08-21 |
2019-02-27 |
Aldeyra Therapeutics, Inc. |
ALDEHYDE CONJUGATES AND USES THEREOF
|
|
US10550085B2
(en)
|
2015-08-21 |
2020-02-04 |
Aldeyra Therapeutics, Inc. |
Deuterated compounds and uses thereof
|
|
EP3419633A4
(en)
|
2016-02-28 |
2019-10-30 |
Aldeyra Therapeutics, Inc. |
TREATMENT OF ALLERGIC EYE DISEASES WITH CYCLODEXTRINS
|
|
JP7116490B2
(ja)
|
2016-05-09 |
2022-08-10 |
アルデイラ セラピューティクス， インコーポレイテッド |
眼の炎症性障害および疾患の組合せ処置
|
|
US20180050989A1
(en)
|
2016-08-22 |
2018-02-22 |
Aldeyra Therapeutics, Inc. |
Aldehyde trapping compounds and uses thereof
|
|
WO2018039197A1
(en)
|
2016-08-22 |
2018-03-01 |
Aldeyra Therapeutics, Inc. |
Aldehyde trapping compounds and methods of use thereof
|
|
WO2018170476A1
(en)
|
2017-03-16 |
2018-09-20 |
Aldeyra Therapeutics, Inc. |
Polymorphic compounds and uses thereof
|